Monomorphic T-cell post-transplant lymphoproliferative disorders exhibit markedly inferior outcomes compared to monomorphic B-cell post-transplant lymphoproliferative disorders-Reference-Cited by-同舟云学术

Monomorphic T-cell post-transplant lymphoproliferative disorders exhibit markedly inferior outcomes compared to monomorphic B-cell post-transplant lymphoproliferative disorders

Published:2010-08-31 Issue:9 Volume:51 Page:1761-1764
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Montanari Francesca,Bhagat Govind,Clark-Garvey Sean,Seshan Venkatraman,Zain Jasmine,Diefenbach Catherine,Mccormick Erin,Crook Meaghan,Conroy Meghan,O'connor Owen A.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2010.500436

Reference14 articles.

1. Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation

2. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation

3. Identification of Prognostic Factors in 61 Patients With Posttransplantation Lymphoproliferative Disorders

4. AN INCREASED INCIDENCE OF EPSTEIN-BARR VIRUS INFECTION AND LYMPHOPROLIFERATIVE DISORDER IN YOUNG CHILDREN ON FK506 AFTER LIVER TRANSPLANTATION1

5. Immunodeficiency-related lymphoproliferative disorders: prospective data from the United Kingdom Children's Cancer Study Group Registry

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Rare Case of Monomorphic T-Cell Posttransplant Lymphoproliferative Disorder Presenting as Primary Cutaneous Anaplastic Large Cell Lymphoma, ALK Negative;The American Journal of Dermatopathology;2022-08-08

2. Durable Response to Brentuximab Vedotin Plus Cyclophosphamide, Doxorubicin, and Prednisone (BV-CHP) in a Patient with CD30-Positive PTCL Arising as a Post-Transplant Lymphoproliferative Disorder (PTLD);Current Oncology;2021-12-02

3. A peripheral T-cell lymphoma (PTCL) arising as a post-transplant lymphoproliferative disorder: efficacy of pralatrexate in primary refractory disease and review of the literature;Leukemia & Lymphoma;2019-06-11

4. Management of Non-Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder;Current Treatment Options in Oncology;2018-05-24

5. T-Cell Acute Lymphoblastic Leukemia After Liver Transplant;Experimental and Clinical Transplantation;2014-03